Real-world treatment patterns for patients with newly diagnosed multiple myeloma in Alberta, Canada-Reference-Cited by-同舟云学术

Real-world treatment patterns for patients with newly diagnosed multiple myeloma in Alberta, Canada

Published:2022-07-05 Issue:11 Volume:63 Page:2557-2564
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Jimenez-Zepeda Victor H.¹²,Chen Guanmin³⁴,Shaw Eileen⁴,Farris Megan S.⁴,Cowling Tara⁴,Tay Jason¹²

Affiliation:

1. Tom Baker Cancer Centre, Alberta Health Services, Calgary, Canada

2. Cumming School of Medicine, University of Calgary, Calgary, Canada

3. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada

4. Medlior Health Outcomes Research Ltd., Calgary, Canada

Funder

Celgene Canada Inc

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2092852

Reference21 articles.

1. Alberta Health Services. Multiple Myeloma Clinical Practice Guideline. 2015.

2. Treatment options for relapsed and refractory multiple myeloma

3. Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

4. Parikh K, Purnomo L, Abouzaid S, et al. Real world treatment patterns, time to next treatment and economic outcomes in relapsed multiple myeloma patients treated with pomalidomide or carfilzomib. 2016 ASCO Annual Meeting; June 6, 2016.

5. Parikh K, Ni Q, Zafar F, et al. Health and Economic Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with RVd Versus CyBord: A U.S. Claims-Based Analysis. AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017; March 27–30, 2017; Denver, Colorado: Journal of Managed Care & Specialty Pharmacy; 2017. p. S33.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma in Latin America: Are we moving at the same pace as other regions?;REV COLOMB CANCEROL;2023

2. Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR);Cancers;2023-02-02